Who invested in Aeglea BioTherapeutics?
Aeglea BioTherapeutics's investors include Venrock, Novartis Venture Fund, Lilly Ventures, UT Horizon Fund and OrbiMed, and 5 more on record.

United States · Funded startup
Funding summaryUpdated 26 Oct 2026
$266Mraised across 3 rounds since 2014, from 3 sources
Each circle is a round, placed by date and sized by amount. The line above is the running total.
Source recordedSEC filing: $210M sold, first sale Jun 2023
From a historical funding recordSEC filing: $44M sold, first sale Mar 2015
From a historical funding recordSEC filing: $5.1M sold, first sale Dec 2013
From the SEC filings it signed: 3 on the team.
On the board, as filediAlison J. LawtonHunter CIvana J. Magovcevic-LiebischMichael J. HendersonPeter J. HarwinRussell J. CoxTomas J. Kiselak
The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.
Aeglea BioTherapeutics's investors include Venrock, Novartis Venture Fund, Lilly Ventures, UT Horizon Fund and OrbiMed, and 5 more on record.
Aeglea BioTherapeutics has raised $266M across 3 rounds since 2014.
Aeglea BioTherapeutics's most recent round was an Undisclosed round of $210M in Jun 2023.
Its most recent round, $210M in Jun 2023, is also its largest on record.
Aeglea BioTherapeutics's first round on record, in Jan 2014, was backed by Novartis Venture Fund, Lilly Ventures and UT Horizon Fund and 3 others.
Aeglea BioTherapeutics's latest named round is an Undisclosed round, in Jun 2023.
Aeglea BioTherapeutics is based in the United States.
Search every investor by what they have actually funded, then narrow to your stage and market. Free.